Premium
Cancer Theranostics: A Tumor Microenvironment‐Responsive Biodegradable Mesoporous Nanosystem for Anti‐Inflammation and Cancer Theranostics (Adv. Healthcare Mater. 2/2020)
Author(s) -
Wu Jianrong,
Niu Shiwei,
Bremner David H.,
Nie Wei,
Fu Zi,
Li Dejian,
Zhu LiMin
Publication year - 2020
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.202070007
Subject(s) - materials science , cancer , nanotechnology , bovine serum albumin , mesoporous material , tumor microenvironment , cancer research , medicine , chemistry , catalysis , immunology , biochemistry
In article number 1901307, Dejian Li, Li‐Min Zhu, and co‐workers, successfully develop an intelligent theranostics platform based on bovine serum albumin‐iridium oxide gated heat shock protein 90 inhibitor‐encapsulated hollow mesoporous organosilica. The resulting AHBIP‐mediated synergistic PTT/PDT offers an outstanding therapeutic outcome.